Cargando…

Inhibition of established collagen-induced arthritis with a tumour necrosis factor-α inhibitor expressed from a self-contained doxycycline regulated plasmid

Tumor necrosis factor (TNF)-α is produced by cells of the immune system and is a key mediator in immune and inflammatory reactions. Through interaction with widely expressed receptors (TNF receptor 1 and TNF receptor 2), TNF-α is able to orchestrate the expression of a range of downstream proinflamm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gould, David J, Bright, Carly, Chernajovsky, Yuti
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC400428/ https://www.ncbi.nlm.nih.gov/pubmed/15059273 http://dx.doi.org/10.1186/ar1036

Ejemplares similares

Gene therapy with an improved doxycycline-regulated plasmid encoding a tumour necrosis factor-alpha inhibitor in experimental arthritis
por: Gould, David, et al.
Publicado: (2007)

Gene therapy for arthritis – where do we stand?
por: Chernajovsky, Yuti
Publicado: (2005)

Novel delivery methods to achieve immunomodulation
por: Gould, David J, et al.
Publicado: (2007)

The differential contribution of tumour necrosis factor to thermal and mechanical hyperalgesia during chronic inflammation
por: Inglis, Julia J, et al.
Publicado: (2005)

Recombinant Galectin-1 and Its Genetic Delivery Suppress Collagen-Induced Arthritis via T Cell Apoptosis
por: Rabinovich, Gabriel A., et al.
Publicado: (1999)

Effects of APC De-Targeting and GAr Modification on the Duration of Luciferase Expression from Plasmid DNA Delivered to Skeletal Muscle
por: Subang, Maria C., et al.
Publicado: (2015)

A novel hybrid promoter responsive to pathophysiological and pharmacological regulation
por: Subang, Maria C., et al.
Publicado: (2011)

Application of regulatable vectors in gene therapy of experimental arthritis
por: Gould, DJ, et al.
Publicado: (2004)

Doxycycline-Induced Expression of Transgenic Human Tumor Necrosis Factor α in Adult Mice Results in Psoriasis-like Arthritis
por: Retser, Eugen, et al.
Publicado: (2013)

Paradoxical effects of tumour necrosis factor-α in adjuvant-induced arthritis
por: Williams, Richard O
Publicado: (2008)

Exogenous tumour necrosis factor α induces suppression of autoimmune arthritis
por: Kim, Eugene Y, et al.
Publicado: (2008)

Effect of an empty plasmid containing CpG on dendritic cells: in vitro steady state of stimulation, in vivo prevention of collagen-induced arthritis
por: Jaen, O, et al.
Publicado: (2004)

Tumor Associated Stromal Cells Play a Critical Role on the Outcome of the Oncolytic Efficacy of Conditionally Replicative Adenoviruses
por: Lopez, M. Verónica, et al.
Publicado: (2009)

Tumour necrosis factor-α in nasal allergy
por: Hisamatsu, K., et al.
Publicado: (1995)

Tumour necrosis factor-α levels are elevated in adolescent patients with juvenile idiopathic arthritis on etanercept therapy
por: Radziszewska, Anna, et al.
Publicado: (2014)

Tumour Necrosis Factor-α Inhibition Improves Stroke Outcome in a Mouse Model of Rheumatoid Arthritis
por: Bonetti, N. R., et al.
Publicado: (2019)

Long-term effectiveness of tumour necrosis factor-α inhibitor treatment for psoriatic arthritis in the UK: a multicentre retrospective study
por: Clunie, Gavin, et al.
Publicado: (2018)

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium
por: Wijbrandts, C A, et al.
Publicado: (2008)

Overnight variations in cortisol, interleukin 6, tumour necrosis factor α and other cytokines in people with rheumatoid arthritis
por: Perry, M G, et al.
Publicado: (2009)

Circulating tumour necrosis factor-α bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response
por: Marotte, Hubert, et al.
Publicado: (2005)

Electrotransfer of low doses of plasmid encoding interleukin-10 in gene therapy of collagen-induced arthritis
por: Boissier, Mc
Publicado: (2002)

In vivo isolated kidney perfusion with tumour necrosis factor α (TNF-α) in tumour-bearing rats
por: Veen, A H van der, et al.
Publicado: (1999)

The influence of tumour necrosis factor α inhibitors treatment – etanercept on serum concentration of biomarkers of inflammation and cartilage turnover in psoriatic arthritis patients
por: Waszczykowski, Michał, et al.
Publicado: (2020)

Influence of tumor necrosis factor α in rheumatoid arthritis
por: Kulp, Werner, et al.
Publicado: (2005)

Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
por: Glossop, John R, et al.
Publicado: (2005)

Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
por: Leandro, Maria J
Publicado: (2009)

Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockade
por: Gompels, Luke L, et al.
Publicado: (2011)

Oxytetracycline versus Doxycycline Collagen Sponges Designed as Potential Carrier Supports in Biomedical Applications
por: Tihan, Graţiela Teodora, et al.
Publicado: (2019)

Assembly PCR synthesis of optimally designed, compact, multi-responsive promoters suited to gene therapy application
por: Mohamed, H., et al.
Publicado: (2016)

Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis
por: Paulos, Chrystal M, et al.
Publicado: (2006)

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
por: Harrold, Leslie R, et al.
Publicado: (2015)

Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis
por: Massey, Jonathan, et al.
Publicado: (2018)

Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers
por: Di Minno, Matteo Nicola Dario, et al.
Publicado: (2014)

Commercially Available Antibodies to Human Tumour Necrosis Factor-α Tested for Cross-Reactivity with Ovine and Bovine Tumour Necrosis Factor-α using Flow Cytometric Assays
por: Dernfalk, J, et al.
Publicado: (2004)

A Study of Single Nucleotide Polymorphisms of Tumour Necrosis Factor α-1031 And Tumour Necrosis Factor β+ 252 in Chronic Rhinosinusitis
por: Misron, Khairunnisak, et al.
Publicado: (2017)

The effect of tumour necrosis factor-α (TNF-α) muteins on human neutrophils in vitro
por: Tchorzewski, H., et al.
Publicado: (1993)

The value of serum type II collagen epitope measurement in assessing early clinical response to treatment with anti-tumour necrosis factor alpha therapy in rheumatoid arthritis
por: Mullan, RH, et al.
Publicado: (2005)

The Jarisch-Herxheimer reaction associated with doxycycline in a patient with Lyme arthritis
por: Nykytyuk, Svitlana, et al.
Publicado: (2020)

Tumour necrosis factor induces increased production of extracellular amyloid-β- and α-synuclein-containing aggregates by human Alzheimer’s disease neurons
por: Whiten, Daniel R, et al.
Publicado: (2020)

Doxycycline Does Not Influence Established Abdominal Aortic Aneurysms in Angiotensin II-Infused Mice
por: Xie, Xiaojie, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g2l42mjmraaqdfqbip9hhrctos